Education
About Us
Working with TipRanks
Follow Us
Ardent Health Partners, Inc. (ARDT)
NYSE:ARDT
ARDT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$12.34 - $20.72
Previous CloseN/A
Volume15.92K
Average Volume (3M)635.55K
Market Cap
$1.85B
Enterprise Value$4.55B
Total Cash (Recent Filing)$556.78M
Total Debt (Recent Filing)$2.28B
Price to Earnings (P/E)8.7
Beta0.06
Next Earnings
Aug 13, 2025EPS Estimate
0.47Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.47
Shares Outstanding142,750,020
10 Day Avg. Volume703,177
30 Day Avg. Volume635,548
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)N/A
Price to Sales (P/S)0.65
Price to Cash Flow (P/CF)5.20
P/FCF Ratio10.10
Enterprise Value/Market Cap2.46
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.33
Enterprise Value/Ebitda7.86
Forecast
1Y Price Target
$20.63Price Target Upside60.92% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
---
Ardent Health Partners, Inc. News
PremiumCompany Announcements
Ardent Health Partners Expands Board with New Appointment
PremiumCompany Announcements
Ardent Health Partners Appoints New Chief Operating Officer
PremiumCompany Announcements
Ardent Health Partners Reports Strong 2024 Financial Results---
Bulls Say, Bears Say
Bulls Say
Acquisition OpportunitiesPotential policy changes could bring more acquisition opportunities for ARDT.
Operational EfficiencyEBITDAR margins improved nicely, with a 330bps year-over-year increase, reflecting better operational efficiency despite past challenges.
Volume And Pricing GrowthStrong revenue, volume, and pricing growth were recorded, with significant increases in admissions and surgical volumes.
Bears Say
Approval DelaysApproval of the New Mexico DPP for 2025 is still pending and may not be reviewed by the end of the first quarter, potentially impacting financial results.
Guidance ConcernsThe 2025 guidance from Ardent Health Partners sits approximately 3% below Street models, though it aligns with prior company commentary.
Regulatory RisksRisks to out-year estimates if Medicaid supplemental and subsidies on exchanges are reduced.
---
Ownership Overview
1.96% Insiders
1.00% Mutual Funds
0.06% Other Institutional Investors
96.50% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ARDT FAQ
What was Ardent Health Partners, Inc.’s price range in the past 12 months?
Ardent Health Partners, Inc. lowest stock price was $12.34 and its highest was $20.72 in the past 12 months.
What is Ardent Health Partners, Inc.’s market cap?
Ardent Health Partners, Inc.’s market cap is $1.85B.
When is Ardent Health Partners, Inc.’s upcoming earnings report date?
Ardent Health Partners, Inc.’s upcoming earnings report date is Aug 13, 2025 which is in 130 days.
How were Ardent Health Partners, Inc.’s earnings last quarter?
Ardent Health Partners, Inc. released its earnings results on Feb 26, 2025. The company reported $0.81 earnings per share for the quarter, beating the consensus estimate of $0.476 by $0.334.
Is Ardent Health Partners, Inc. overvalued?
According to Wall Street analysts Ardent Health Partners, Inc.’s price is currently Undervalued.
Does Ardent Health Partners, Inc. pay dividends?
Ardent Health Partners, Inc. does not currently pay dividends.
What is Ardent Health Partners, Inc.’s EPS estimate?
Ardent Health Partners, Inc.’s EPS estimate is 0.47.
How many shares outstanding does Ardent Health Partners, Inc. have?
Ardent Health Partners, Inc. has 142,750,020 shares outstanding.
What happened to Ardent Health Partners, Inc.’s price movement after its last earnings report?
Ardent Health Partners, Inc. reported an EPS of $0.81 in its last earnings report, beating expectations of $0.476. Following the earnings report the stock price went up 8.208%.
Which hedge fund is a major shareholder of Ardent Health Partners, Inc.?
Currently, no hedge funds are holding shares in ARDT
---
Ardent Health Partners, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$20.63 (60.92% Upside)
$20.63 (60.92% Upside)
Hedge Fund Trend
Decreased
By 205.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $339.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 5.3%
Last 30 Days ▼ 0.2%
Last 30 Days ▼ 0.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Fundamentals
Return on Equity
23.34%
Trailing 12-Months
Asset Growth
4.41%
Trailing 12-Months
Company Description
Ardent Health Partners, Inc.
Ardent Health Partners, Inc. (ARDT) is a healthcare services company based in the United States. The company operates a network of hospitals, clinics, and outpatient facilities, providing a wide range of healthcare services including acute care, emergency care, and specialized medical treatments. Ardent Health Partners is committed to delivering high-quality patient care through its community-focused healthcare facilities and partnerships with healthcare professionals.
---
ARDT Company Deck
---
ARDT Earnings Call
Q4 2025
0:00 / 0:00
---
ARDT Stock 12 Month Forecast
Average Price Target
$20.63
▲(60.92% Upside)
Technical Analysis
Acadia Healthcare
―
Community Health
―
HCA Healthcare
―
Tenet Healthcare
―
Universal Health
―
Best Analysts Covering ARDT
1 Year
1 Year Success Rate
0/6 ratings generated profit
1 Year Average Return
-18.22%
reiterated a buy rating 4 days ago
Copying Whit Mayo's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -18.22% per trade.
---